Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 162 (3) , 575-583
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysisBMJ, 2014
- Optimization of HPV DNA detection in urine by improving collection, storage, and extractionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2014
- Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysisThe Lancet Oncology, 2014
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- Detection of human papillomavirus DNA in urine. A review of the literatureEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Principles and analytical performance of Abbott RealTime High Risk HPV testJournal of Clinical Virology, 2009
- Papillomaviruses in the causation of human cancers — a brief historical accountVirology, 2009
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid‐based cytology*Cytopathology, 2007